Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
On September 23, 2020, the Equator Principles Association released a series of guidance notes to support the implementation of the updated Equator Principles (EP4), which came into full effect on October 1, 2020.
Among other revisions, one of the key updates that appears in EP4 is the additional guidance it provides regarding stakeholder engagement with Indigenous Peoples (which is a defined term) and the concept of Free, Prior and Informed Consent (FPIC). These changes are something that stakeholders in Designated Countries, including Canada, will want to be aware of and ready for in the context of project financing to which EP4 now applies.
While each project may require its own full assessment, this publication provides a high-level benchmarking of the requirements of IFC Performance Standard 7 against Canadian law, as it relates to engagement with Indigenous Peoples. This comparative analysis reveals that overall, there is substantial alignment between most of the key elements and goals of IFC Performance Standard 7 and Canada’s legal framework, and Canada’s legal framework includes mechanisms through which many of the same goals and outcomes of IFC Performance Standard 7 and EP4 can be achieved. The guidance notes can be found here.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025